Featured Stories
#MedSafetyWeek – Every Report Counts and Can Help Others in the Future
Medis regularly encourages its employees to provide the necessary information from the market to ensure the best treatment options for our patients.
Read More
First-Hand Experience with Imunoglukan – Story of Nadja
For Nadja Ott, a pharmacist and Brand Manager, this period at Medis is very stressful, but at the same time, it is also exciting.
Read More
We Maintain the Best Balance Between Development and Risk
Interview with Erna Slana, Managing Director of the Finance and Accounting Division at Medis.
Read More
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read More
Medis Received the Platinum Creditworthiness Certificate of Excellence for 2020
The Bisnode Analytics Services has ranked Medis among the 1.5% of the most successful, reliable, credible and low-risk companies for cooperation with other...
Read More
A new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read More